Phosphatidylserine as a tumor target for CAR-T cell therapy.
Saved in:
| Title: | Phosphatidylserine as a tumor target for CAR-T cell therapy. |
|---|---|
| Authors: | Martín-Otal C; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain., Sánchez-Moreno I; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain., Gómez-Morón A; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain., Castro C; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain., Casares N; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain., Navarro F; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain., Gorraiz M; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain., Justicia-Lirio P; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain., Pareja F; Department of Nuclear Medicine, CIMA Universidad de Navarra, Pamplona, Spain., Collantes M; Department of Nuclear Medicine, CIMA Universidad de Navarra, Pamplona, Spain., Peñuelas I; Department of Nuclear Medicine, CIMA Universidad de Navarra, Pamplona, Spain., Iñarrairaegui M; IdiSNA, Pamplona, Spain.; Liver Unit, University Clinic of Navarra, Pamplona, Spain., Sangro B; IdiSNA, Pamplona, Spain.; Liver Unit, University Clinic of Navarra, Pamplona, Spain., Vivas I; IdiSNA, Pamplona, Spain.; Radiology, University Clinic of Navarra, Pamplona, Spain., Larrayoz M; IdiSNA, Pamplona, Spain.; Hemato-Oncology Program, CIMA Universidad de Navarra, Pamplona, Spain., Rodriguez JR; IdiSNA, Pamplona, Spain.; Hemato-Oncology Program, CIMA Universidad de Navarra, Pamplona, Spain., Prosper F; IdiSNA, Pamplona, Spain.; Hematology and Cell Therapy Department, University Clinic of Navarra, Pamplona, Spain., Hervas-Stubbs S; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain.; IdiSNA, Pamplona, Spain., Martin-Cofreces N; CIBERCV, Madrid, Community of Madrid, Spain., Lasarte JJ; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain jjlasarte@unav.es.; IdiSNA, Pamplona, Spain., Lozano T; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain.; IdiSNA, Pamplona, Spain. |
| Source: | Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Feb 23; Vol. 13 (2). Date of Electronic Publication: 2025 Feb 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
